Effects of empagliflozin on exercise tolerance and left ventricular diastolic function in patients with heart failure with preserved ejection fraction and type 2 diabetes: a prospective single-center study
Aim. To assess the effect of the sodium-glucose transport protein 2 inhibitor empagliflozin on exercise tolerance and left ventricular (LV) diastolic function in patients with heart failure with preserved ejection fraction (HFpEF) and type 2 diabetes (T2D).Material and methods. The present prospecti...
Saved in:
| Main Authors: | A. G. Ovchinnikov, A. A. Borisov, K. Yu. Zherebchikova, O. Yu. Ryabtseva, A. D. Gvozdeva, V. P. Masenko, F. T. Ageev, S. A. Boytsov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2021-02-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/4304 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of empagliflozin on functional capacity, LV filling pressure, and cardiac reserves in patients with type 2 diabetes mellitus and heart failure with preserved ejection fraction: a randomized controlled open-label trial
by: Artem Ovchinnikov, et al.
Published: (2025-05-01) -
Relationship between plasma aldosterone and left ventricular structure and function in patients with heart failure with preserved ejection fraction
by: A. N. Shevelok
Published: (2021-03-01) -
Diastolic heart failure: boundaries of term application
by: V. V. Kalyuzhin, et al.
Published: (2023-04-01) -
Modern echocardiographic criteria for heart failure with preserved ejection fraction: not only diastolic dysfunction
by: O. M. Drapkina, et al.
Published: (2020-04-01) -
FEATURES OF LEFT VENTRICLE DIASTOLIC DYSFUNCTION IN SYPHILITIC HEART DISEASE
by: V. V. Anikin, et al.
Published: (2003-10-01)